Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP708582.RANXy9oOkv07UrgKWGGKGTHVt9s4-_VVED3Y-O3DOC2AA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP708582.RANXy9oOkv07UrgKWGGKGTHVt9s4-_VVED3Y-O3DOC2AA130_assertion type Assertion NP708582.RANXy9oOkv07UrgKWGGKGTHVt9s4-_VVED3Y-O3DOC2AA130_head.
- NP708582.RANXy9oOkv07UrgKWGGKGTHVt9s4-_VVED3Y-O3DOC2AA130_assertion description "[These findings mechanistically implicate HDAC7 and Nur77 in sensitizing human CTCL cells to panobinostat as well as suggest that cotreatment with an anti-Bcl-2 agent would augment the anti-CTCL activity of panobinostat.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP708582.RANXy9oOkv07UrgKWGGKGTHVt9s4-_VVED3Y-O3DOC2AA130_provenance.
- NP708582.RANXy9oOkv07UrgKWGGKGTHVt9s4-_VVED3Y-O3DOC2AA130_assertion evidence source_evidence_literature NP708582.RANXy9oOkv07UrgKWGGKGTHVt9s4-_VVED3Y-O3DOC2AA130_provenance.
- NP708582.RANXy9oOkv07UrgKWGGKGTHVt9s4-_VVED3Y-O3DOC2AA130_assertion SIO_000772 19074726 NP708582.RANXy9oOkv07UrgKWGGKGTHVt9s4-_VVED3Y-O3DOC2AA130_provenance.
- NP708582.RANXy9oOkv07UrgKWGGKGTHVt9s4-_VVED3Y-O3DOC2AA130_assertion wasDerivedFrom befree-2016 NP708582.RANXy9oOkv07UrgKWGGKGTHVt9s4-_VVED3Y-O3DOC2AA130_provenance.
- NP708582.RANXy9oOkv07UrgKWGGKGTHVt9s4-_VVED3Y-O3DOC2AA130_assertion wasGeneratedBy ECO_0000203 NP708582.RANXy9oOkv07UrgKWGGKGTHVt9s4-_VVED3Y-O3DOC2AA130_provenance.